AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
With a market cap of 257.93B, AstraZeneca(AZN) trades at $166.28. The stock has a price-to-earnings ratio of 24.72 and currently yields dividends of 1.68%.
On 2026-09-29, AstraZeneca(AZN) stock moved within a range of $165.10 to $167.52. With shares now at $166.28, the stock is trading +0.7% above its intraday low and -0.7% below the session's peak.
Trading activity shows a volume of 1.57M, compared to an average daily volume of 2.83M.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $147.37.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $147.37.
AZN News
...
Major indices started the week on a downswing as oil prices sprang higher after President Donald Trump rejected conditions for a ceasefire presented by Iran and...
AstraZeneca is investing $2 billion into Summit Therapeutics as part of an expanded partnership. Avishek Das / Zuma Press AstraZeneca AZN -0.48 %decrease; down...
Analyst ratings
100%
of 10 ratingsMore AZN News
Summit (SMMT) and AstraZeneca (ANZ) announced on Monday that the companies have entered into an agreement whereby AstraZeneca will make an equity investment of...
...
Summit (SMMT) entered into a clinical collaboration agreement with AstraZeneca (AZN) to evaluate sonesitatug vedotin in combination with ivonescimab with the in...
Summit Therapeutics (SMMT) announced key developments important to the company’s progress towards achieving its goal of making a significant difference in the l...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) has completed a Phase I study titled “A Phase I, Randomized, Op...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study Real World Study of Effectiveness of Sunitinib or Sorafenib looks at how two...
AstraZeneca’s (AZN) supplemental Biologics License Application for IMFINZI in combination with enfortumab vedotin has been accepted and granted Priority Review...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.